Evidence map›Paper›PMID 33012888›Full record

ReviewColombia medica (Cali, Colombia)2020

Learning from combination HIV prevention programmes to face COVID-19 emerging pandemic.

Ricardo Palacios, Augusto Mathias

Abstract readReview
In one paragraph

Review in Colombia medica (Cali, Colombia), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ricardo PalaciosInstituto Butantan, Clinical Trials and Pharmacovigilance Center, São Paulo, Brazil.ORCID 0000-0002-1410-8579
Augusto MathiasUniversidade de São Paulo, School of Medicine, Department of Preventive Medicine, São Paulo, Brazil.ORCID 0000-0002-5896-9223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Before a vaccine against SARS-CoV-2 became available, several measures to control COVID-19 pandemic are necessary. Analogously, in the absence of an available vaccine, Combination HIV Prevention Programmes have consolidated a large experience of biomedical, behavioral and structural interventions suitable for several epidemiological settings. Adaptation of such experiences can organize mid-term and long-term responses to face COVID-19.

Indexed as

Coronavirus InfectionsCOVID-19COVID-19 VaccinesHIV InfectionsHumansPandemicsPneumonia, ViralViral VaccinesCOVID-19 VaccinesViral VaccinesAcquired Immunodeficiency SyndromeCoronavirusCoronavirus InfectionsCOVID-19GovernmentImmunizationPandemicsSevere Acute Respiratory Syndromesevere acute respiratory syndrome coronavirus 2United NationsVaccinationVaccines

Identifiers

PMID33012888
PMCPMC7518725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.